View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Premium Brands Holdings Corporation Announces $150 Million Financing o...

Premium Brands Holdings Corporation Announces $150 Million Financing of Convertible Unsecured Subordinated Debentures NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 05, 2025 (GLOBE NEWSWIRE) -- Premium Brands Holdings Corporation (“Premium Brands” or the “Company”) (TSX: PBH), a leading producer, marketer and distributor of branded specialty food products, is pleased to announce it has entered into an agreement with a syndicate of underwriters co-led by CIBC Capital Markets, National Bank Financial, BMO Capital Markets ...

 PRESS RELEASE

COMPX DECLARES REGULAR QUARTERLY DIVIDEND

COMPX DECLARES REGULAR QUARTERLY DIVIDEND Dallas, Texas, March 05, 2025 (GLOBE NEWSWIRE) -- CompX International Inc. (NYSE American:  CIX) announced today that its board of directors has declared CompX’s regular quarterly dividend of thirty cents ($0.30) per share on its class A common stock, payable on March 25, 2025 to stockholders of record at the close of business on March 17, 2025. CompX is a leading manufacturer of security products and recreational marine components. * * * * Investor Relations Contact Bryan A. HanleySenior Vice President and TreasurerTel. 972-233-1700

 PRESS RELEASE

Clarus Announces $0.025 Per Share Quarterly Dividend

Clarus Announces $0.025 Per Share Quarterly Dividend SALT LAKE CITY, March 05, 2025 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor enthusiast markets, announced that its board of directors has confirmed the Company’s regular quarterly cash dividend of $0.025 per share. The cash dividend will be paid on March 26, 2025, to all stockholders of record as of March 17, 2025. About Clarus CorporationHeadquartered in Salt Lake City, Utah, Clarus Corporation is a global leader in the design and development of best-in...

 PRESS RELEASE

NCS Multistage Holdings, Inc. Schedules Fourth Quarter and Full Year 2...

NCS Multistage Holdings, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call HOUSTON, March 05, 2025 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (“NCS” or the “Company”) (NASDAQ:NCSM) will host a conference call to discuss its fourth quarter and full year 2024 results on Tuesday March 11, 2025 at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). NCS will issue its fourth quarter and full year 2024 earnings release the evening prior to the conference call. The conference call will be available via a live audio webcast. Participants who wish to ask qu...

 PRESS RELEASE

Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement

Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement WALTHAM, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO) today announced that it has received notice from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with the Nasdaq Capital Market’s minimum stockholders’ equity requirement as required by Nasdaq Listing Rule 5550(b)(1). On February 26, 2025, Mustang received formal notice from Nasdaq confirming that the Company has satisfied the minimum stockholders’ equity requirem...

 PRESS RELEASE

Victoria’s Secret & Co. Reports Fourth Quarter 2024 Results

Victoria’s Secret & Co. Reports Fourth Quarter 2024 Results Fourth quarter comparable sales increase 5%Operating Income and EPS exceed expectationsProvides initial full year and first quarter 2025 guidance REYNOLDSBURG, Ohio, March 05, 2025 (GLOBE NEWSWIRE) -- Victoria’s Secret & Co. (“VS&Co” or the “Company”) (NYSE: VSCO) today reported financial results for the fourth quarter and fiscal year ended February 1, 2025. “I am pleased with the strength of our fourth quarter holiday results, which saw sales up in both our Victoria’s Secret and PINK brands and our powerhouse Beauty busine...

 PRESS RELEASE

COMPX REPORTS FOURTH QUARTER 2024 RESULTS

COMPX REPORTS FOURTH QUARTER 2024 RESULTS Dallas, Texas, March 05, 2025 (GLOBE NEWSWIRE) -- CompX International Inc. (NYSE American: CIX) announced today net sales of $38.4 million for the fourth quarter of 2024 compared to $43.2 million in the same period of 2023. Operating income was $4.9 million in the fourth quarter of 2024 compared to $7.4 million in the same period of 2023. Net income was $4.5 million, or $.37 per basic and diluted common share, for the fourth quarter of 2024 compared to $6.7 million, or $.54 per basic and diluted common share, in the same period of 2023. Net sales...

 PRESS RELEASE

Alta Equipment Group Announces Fourth Quarter and Full Year 2024 Finan...

Alta Equipment Group Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Adjusted EBITDA Guidance for 2025 Equipment Fleet and Working Capital Management Generate Strong Fourth Quarter Cash Flows as Pressured Volumes and Gross Margins on Equipment Sales Drive Quarterly and Annual Earnings Decline Fourth Quarter Financial Highlights: (comparisons are year over year) Total revenues decreased 4.5% year over year to $498.1 millionConstruction and Material Handling revenues of $318.6 million and $168.6 million, respectivelyProduct support revenues decreased 2.3% year ov...

 PRESS RELEASE

CoreCivic Announces Resumption of Operations at South Texas Family Res...

CoreCivic Announces Resumption of Operations at South Texas Family Residential Center in Dilley, Texas BRENTWOOD, Tenn., March 05, 2025 (GLOBE NEWSWIRE) -- CoreCivic, Inc. (NYSE: CXW) ("CoreCivic") announced today that it has agreed under an amended intergovernmental services agreement (IGSA) between the City of Dilley, Texas, and U.S. Immigration and Customs Enforcement (ICE) to resume operations and care for up to 2,400 individuals at the South Texas Family Residential Center in Dilley, Texas (the Dilley Facility). Simultaneously, CoreCivic has entered into a new lease agreement with Ta...

 PRESS RELEASE

Certara Appoints Dr. Adrian McKemey as President of Drug Development S...

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions McKemey joins Certara to accelerate growth of its strategic drug development solutions RADNOR, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of Adrian McKemey, Ph.D. as President of Drug Development Solutions, effective March 3rd, 2025. In this role, McKemey will lead Certara's global team of drug development scientists. Adrian joins Certara after serving as head of Enterprise Transformation at IQVIA a...

ADDvise Group AB: 2 directors

Two Directors at ADDvise Group AB bought 1,159,717 shares at between 2.330SEK and 2.512SEK. The significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...

Chemtrade Logistics Income Fund: 1 director

A director at Chemtrade Logistics Income Fund bought 5,000 shares at 9.650CAD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...

 PRESS RELEASE

Rigetti Computing Reports Fourth Quarter and Full-Year 2024 Results

Rigetti Computing Reports Fourth Quarter and Full-Year 2024 Results BERKELEY, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced its financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter and Full-Year 2024 Financial Highlights Revenues for the three months ended December 31, 2024 were $2.3 millionOperating expenses for the three months ended December 31, 2024 were $19.5 millionOperating loss for the three months ended Decem...

 PRESS RELEASE

Alto Ingredients, Inc. Reports Fourth Quarter and Year-end 2024 Result...

Alto Ingredients, Inc. Reports Fourth Quarter and Year-end 2024 Results - Implemented Cost Savings Expected to Yield Approximately $8 Million Annually - - Integrated Accretive Acquisition of a Beverage-grade Liquid CO2 Processor -- Considering Asset Sales, a Merger or Other Strategic Transactions - PEKIN, Ill., March 05, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, reported its financial results for the quarter and year ended December 31, 2024. Bryon McGregor, Presiden...

 PRESS RELEASE

Climb Global Solutions Reports Record Fourth Quarter and Full Year 202...

Climb Global Solutions Reports Record Fourth Quarter and Full Year 2024 Results FY 2024 Net Income up 51% to $18.6 Million or $4.06 per share; Adjusted Net Income up 64% to $24.0 Million or $5.26 per share; Adjusted EBITDA up 61% to $39.6 Million Q4 & FY 2024 Net Sales, Gross Profit, Net Income, EPS and Adjusted EBITDA Increase to Record Levels EATONTOWN, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology ven...

 PRESS RELEASE

Zscaler Reports Second Quarter Fiscal 2025 Financial Results

Zscaler Reports Second Quarter Fiscal 2025 Financial Results Second Quarter Highlights Revenue grows 23% year-over-year to $647.9 millionCalculated billings grows 18% year-over-year to $742.7 millionDeferred revenue grows 25% year-over-year to $1,878.5 millionGAAP net loss of $7.7 million compared to GAAP net loss of $28.5 million on a year-over-year basis Non-GAAP net income of $127.1 million compared to non-GAAP net income of $99.4 million on a year-over-year basis SAN JOSE, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Zscaler, Inc. (Nasdaq: ZS), the leader in cloud security, today ...

 PRESS RELEASE

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Res...

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance MENLO PARK, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today reported financial results for the fourth quarter and full year ended December 31, 2024 and initiated financial guidance for full year 2025. Recent Financial Highlights Generated fourth qua...

 PRESS RELEASE

Methode Electronics, Inc. Reports Fiscal 2025 Third Quarter Financial ...

Methode Electronics, Inc. Reports Fiscal 2025 Third Quarter Financial Results Strong Power Product Sales for Data Centers Positive Free Cash FlowTransformation Journey Well UnderwayGuidance Reaffirmed for Fiscal 2026 CHICAGO, March 05, 2025 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, lighting, and power distribution applications, today announced financial results for the third quarter of fiscal 2025 ended February 1, 2025. Fiscal Third Quarter 2025 Results Net sales were ...

 PRESS RELEASE

Vaxart Announces Publication Demonstrating the Immunogenicity and Safe...

Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults Robust, antigen-specific responses in the nasal cavity following oral administration underscore the efficiency of Vaxart’s oral vaccine platform in generating mucosal antibody responses beyond the site of administration SOUTH SAN FRANCISCO, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that complete data from the Phase 1b trial of its first-generation oral pill norovirus vaccine candidate in elde...

 PRESS RELEASE

Yext Announces Fourth Quarter Fiscal 2025 Results

NEW YORK--(BUSINESS WIRE)-- Yext, Inc. (NYSE: YEXT), the leading digital presence platform for multi-location brands, today announced its results for the three months ended January 31, 2025, or Yext's fourth quarter and fiscal year ended January 31, 2025. For more detailed information on Yext's operating and financial results for the fourth quarter fiscal 2025, fiscal year ended January 31, 2025, as well as Yext's outlook for its first quarter ending April 30, 2025 and fiscal year 2026, please refer to the Letter to Shareholders, which can be found on the Yext Investor Relations website at . ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch